beeldscherm schreef op 24 januari 2018 12:46:
FDA Grants Approval to Shire for Technology Transfer of CINRYZE® Drug Product Manufacturing Process to Vienna, Austria Manufacturing Site.
globenewswire.com/news-release/2018/0.....Shire will begin commercial manufacturing of Cinryze drug product in Vienna in the first quarter of 2018. Cinryze will also continue to be produced by a third-party supplier, providing an additional supply source to meet patient demand.
..
CINRYZE® (C1 esterase inhibitor [human]) is one of the leading therapies approved for the treatment of HAE in adolescent and adult patients.
daar stond vroeger toch, The leading therapy
dus 2e kw pas uitleveren..